Epilepsy Care Considerations for School Nurses: Stigma and Sudden Unexplained Death in Epilepsy (SUDEP)

Release Date: 06/08/2023
Expiration Date: 06/08/2026

Cost: Free for NASN members and non members!

Instructions to Successfully Complete This NCPD Program
To receive a Certificate of Completion and be awarded NCPD contact hours for this program, follow the steps below, and complete and view the full content of the program including the program evaluation. If a post assessment is included in the content, you will need to have 75% of the answer correct in order to pass the assessment. You will also have unlimited retakes on the assessment.

NASN will conduct an outcome assessment of a sample of participants at a later date. Please be advised that, if you complete this program, you may be asked to participate in this outcome assessment.

Step 1: Enroll in the program through the e-commerce system. Select the Purchase button. You will be directed to the e-commerce system. The program should already be in your shopping cart (look for the shopping cart icon at the top of the e-commerce web page). Select the shopping card and choose "check out." You will receive a confirmation email with a link back to this program after your transaction.

Step 2: Complete and view the full content of the program. Content items are indexed at the bottom of this screen. After you enroll, you will return to this screen. The first content item will be “unlocked” so that you can begin completing the course. Subsequent items will “unlock” as you complete previous items.

Step 3: Retrieve the certificate.  After completing all content items, you will earn a certificate. You can save or print it.  Certificates are also stored in your Learning Center Profile.

Program Overview
This course will provide school nurses information on the impact of stigma for students with seizures/epilepsy, including the identification of stigma and strategies to reduce it, and on Sudden Unexplained Death in Epilepsy (SUDEP) risks, causes, and methods to inform others that will afford the opportunity to transform school nurse practice. 

Learning Outcomes

• Describe the incidence and impact of stigma for students with seizures/epilepsy.
• Describe methods/tools to identify stigma for students with seizures/epilepsy.
• Identify at least three strategies to reduce stigma for students with epilepsy using the school nursing practice using the NASN Framework.
• Describe the definition, incidence, causes, risks factors for SUDEP.
• Describe methods to inform and support school staff and families.
• List 3 SUDEP prevention resources and understand the limitations of the devices.

Intended Audience

This nursing continuing professional development program is developed to meet the educational needs in the area of with knowledge and practice for registered nurses who are interested in child, adolescent health, community/public health, and school nursing.

Faculty

Andrea Tanner, PhD, RN, NCSN
Consulting Research Strategist
National Association of School Nurses

Patricia Osborne Shafer, RN, MN, FAES
Epilepsy Nurse Specialist, Healthcare Consultant

Faculty and Nurse Planner(s) Disclosures
NASN must ensure that all educational program content is free of commercial interest, bias, influence, and that the integrity of the content is uncompromised. The intent of this disclosure is to provide learners with information on which they can make their own judgments.

The nurse planner(s), faculty, and reviewers disclose there are no relevant financial relationships with ineligible companies for those involved with the ability to control the content of this program.

Accreditation Statement
The National Association of School Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Accredited status does not imply endorsement by NASN or ANCC of any commercial products discussed in this learning program.

Commercial Support or Grant Funding
This program was supported by an educational grant from the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of as part of a financial assistance award totaling $300,000 with 100 percent funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official view of, nor an endorsement by, CDC/HHS, or the U.S. Government.